僅用于工業(yè)應(yīng)用或科學(xué)研究，不可用于人類或動物的臨床診斷或治療，非藥用. Mavrilimumab （CAM 3001） is a monoclonal antibody that binds to the α subunit of the granulocyte-macrophage colony stimulating factor （GM-CSF） receptor and blocks intracellular signalling downstream of GM-CSF. GM-CSF might be a mediator of the hyperactive inflammatory response associated with respiratory failure and death